A Phase 3, Multicenter, Open-label Extension Study of Buccally Administered MHOS/SHP615 in Pediatric Patients With Status Epilepticus (Convulsive) in Community Settings
Phase of Trial: Phase III
Latest Information Update: 18 Jul 2018
At a glance
- Drugs Midazolam (Primary)
- Indications Status epilepticus
- Focus Therapeutic Use
- Sponsors Shire
- 06 Jul 2018 Status changed from not yet recruiting to recruiting.
- 21 Dec 2017 Planned initiation date changed from 7 Nov 2017 to 30 Dec 2017.
- 14 Nov 2017 New trial record